Search Results - "Stolker, Joshua M."

Refine Results
  1. 1
  2. 2

    Comparison of In-Hospital Outcomes for Beta-Blocker Use Versus Non–Beta Blocker Use in Patients Presenting With Cocaine-Associated Chest Pain by Fanari, Zaher, MD, Kennedy, Kevin K., MD, Lim, Michael J., MD, Laddu, Abhay A., MD, Stolker, Joshua M., MD

    Published in The American journal of cardiology (01-06-2014)
    “…Beta blockers are indicated for management of acute coronary syndromes, but they generally are withheld in patients with cocaine-associated chest pain because…”
    Get full text
    Journal Article
  3. 3

    Cardiovascular safety of liraglutide assessed in a patient-level pooled analysis of phase 2: 3 liraglutide clinical development studies by Marso, Steven P, Lindsey, Jason B, Stolker, Joshua M, House, John A, Martinez Ravn, Gabriela, Kennedy, Kevin F, Jensen, Troels M, Buse, John B

    Published in Diabetes & vascular disease research (01-07-2011)
    “…We assessed the cardiovascular safety of liraglutide, a glucagon-like peptide-1 receptor agonist, using existing clinical data. Patient-level results from all…”
    Get more information
    Journal Article
  4. 4

    Relationship between stent type and quality of life after percutaneous coronary intervention for acute myocardial infarction by Chhatriwalla, Adnan K., MD, Venkitachalam, Lakshmi, PhD, Kennedy, Kevin F., MS, Stolker, Joshua M., MD, Jones, Philip G., MS, Cohen, David J., MD, MSc, Spertus, John A., MD, MPH

    Published in The American heart journal (01-10-2015)
    “…Background Drug-eluting stents (DES) reduce restenosis, as compared with bare-metal stents (BMS); however, the relationship between stent type and health…”
    Get full text
    Journal Article
  5. 5

    Incremental Utility of Iodine-123 Meta-Iodobenzylguanidine Imaging Beyond Established Heart Failure Risk Models by Jain, Kaushik K., DO, Hauptman, Paul J., MD, Spertus, John A., MD, MPH, Kennedy, Kevin F., MS, Bateman, Timothy M., MD, Jacobson, Arnold F., MD, PhD, Stolker, Joshua M., MD

    Published in Journal of cardiac failure (01-08-2014)
    “…Abstract Background Nuclear myocardial imaging with iodine-123 meta-iodobenzylguanidine (123 I- m IBG) is approved for risk stratification of patients with…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Mode of death after contemporary percutaneous coronary intervention: A report from the Evaluation of Drug Eluting Stents and Ischemic Events registry by Stolker, Joshua M., MD, Cohen, David J., MD, MSc, Lindsey, Jason B., MD, Kennedy, Kevin F., MS, Kleiman, Neal S., MD, Marso, Steven P., MD

    Published in The American heart journal (01-11-2011)
    “…Background When selecting clinical trial end points, some investigators prefer cardiovascular death (CVD) while others believe that all-cause mortality is more…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Rethinking Composite End Points in Clinical Trials: Insights From Patients and Trialists by Stolker, Joshua M, Spertus, John A, Cohen, David J, Jones, Philip G, Jain, Kaushik K, Bamberger, Emily, Lonergan, Brady B, Chan, Paul S

    Published in Circulation (New York, N.Y.) (07-10-2014)
    “…BACKGROUND—Many clinical trials use composite end points to reduce sample size, but the relative importance of each individual end point within the composite…”
    Get full text
    Journal Article
  10. 10

    Transparency of Appropriateness Criteria by Stolker, Joshua M., MD, Lindsey, Jason B., MD, Marso, Steven P., MD

    “…Recent analyses by leading cardiovascular investigators have noted the lack of a rigorous evidence base for many of the guideline recommendations, as nearly…”
    Get full text
    Journal Article
  11. 11

    Electrical Triggers of Adverse Events During the Baseball World Series by Stolker, Joshua M., Aziz, Zaid, Kennedy, Kevin F., Hauptman, Paul J.

    Published in The American journal of cardiology (15-11-2018)
    “…Adverse cardiovascular events occur more frequently during times of community stress, including natural disasters, wars and terrorist attacks, and even during…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Defining the Severity and Duration of Health Status Decrements Due to Restenosis by Stolker, Joshua M., Jones, Philip G., Spertus, John A.

    Published in The American journal of cardiology (01-05-2018)
    “…Research Letter Percutaneous coronary intervention (PCI) reduces angina and improves quality of life.1–3 However, restenosis requiring target vessel…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction by Shore, Supriya, Jones, Philip G, Maddox, Thomas M, Bradley, Steven M, Stolker, Joshua M, Arnold, Suzanne V, Parashar, Susmita, Peterson, Pamela, Bhatt, Deepak L, Spertus, John, Ho, P Michael

    Published in Heart (British Cardiac Society) (15-05-2015)
    “…Prior studies have demonstrated that patients with high-risk acute myocardial infarction (AMI) are less likely to receive guideline-directed medications during…”
    Get more information
    Journal Article
  16. 16

    Ischemic Stroke with Troponin Elevation: Patient Characteristics, Resource Utilization, and In-Hospital Outcomes by Peddada, Krishi, Cruz-Flores, Salvador, Goldstein, Larry B, Feen, Eliahu, Kennedy, Kevin F, Heuring, Timothy, Stolker, Joshua M

    “…Among patients hospitalized for acute ischemic stroke, abnormal serum troponins are associated with higher risk of short-term mortality. However, most findings…”
    Get more information
    Journal Article
  17. 17

    Recurrent Takotsubo Cardiomyopathy Related to Recurrent Thyrotoxicosis by Patel, Keval, Griffing, George T, Hauptman, Paul J, Stolker, Joshua M

    Published in Texas Heart Institute journal (01-04-2016)
    “…Takotsubo cardiomyopathy, or transient left ventricular apical ballooning syndrome, is characterized by acute left ventricular dysfunction caused by transient…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Predicting Adverse Outcomes After Myocardial Infarction Among Patients With Diabetes Mellitus by Arnold, Suzanne V, Spertus, John A, Jones, Philip G, McGuire, Darren K, Lipska, Kasia J, Xu, Yaping, Stolker, Joshua M, Goyal, Abhinav, Kosiborod, Mikhail

    “…Although patients with diabetes mellitus experience high rates of adverse events after acute myocardial infarction (AMI), including death and recurrent…”
    Get full text
    Journal Article